Effects of a Hybrid Digital Cognitive-behavioural Therapy for Insomnia and Emotion Regulation in the Workplace (SLEEP): Study Protocol for a Randomised Waitlist Control Trial

Overview

Journal BMJ Open

Specialty General Medicine

Date 2022 Jul 15

PMID 35840305

Authors

Talar Rita Moukhtarian

Krishane Patel

Carla Toro

Sean Russel

Guy Daly

Lukasz Walasek

Nicole K Y Tang

Caroline Meyer

Affiliations

Soon will be listed here.

Abstract

Introduction: This trial tests the efficacy of implementing a hybrid digital cognitive-behavioural therapy for insomnia (dCBT-I) and emotion regulation (ER) in the workplace. The study protocol follows the SPIRIT (Standard Protocol Items: Recommendations for Intervention Trials) 2013 recommendations.

Methods And Analysis: This is a mixed methods evaluation with a two-arm randomised waitlist control design of a 6-week dCBT-I+ER intervention through self-guided online platform and four videoconferencing therapy sessions. A process evaluation will examine the fidelity of delivery and experiences of the intervention. The primary outcomes are the Insomnia Severity Index, the Patient Health Questionnaire-9 and the Generalised Anxiety Disorder-7. The secondary outcomes are job productivity, job satisfaction, well-being, quality of life, self-reported (sleep diary data) and objective (actigraphy) sleep parameters, and usage of online intervention platform. Assessments take place at baseline (T0), week 8 post-treatment (T1) and week 12 postrandomisation (T2). We will recruit 156 workers with sleep and ER problems ranging from subclinical to clinical levels not engaged in treatment at the time of the trial.

Ethics And Dissemination: Full approval was given by the University of Warwick Biomedical and Research Ethics Committee (BSREC 45/20-21). The current protocol version is 2.9_Dec21. Publication of results will inform the scientific, clinical and business communities through peer-reviewed articles, webinars, conferences and newsletters.

Trial Registration Number: ISRCTN13596153.

References

Tang N, Goodchild C, Salkovskis P . Hybrid cognitive-behaviour therapy for individuals with insomnia and chronic pain: a pilot randomised controlled trial. Behav Res Ther. 2012; 50(12):814-21. DOI: 10.1016/j.brat.2012.08.006. View

Cappuccio F, DElia L, Strazzullo P, Miller M . Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009; 33(2):414-20. PMC: 2809295. DOI: 10.2337/dc09-1124. View

Zhang W, Bansback N, Boonen A, Young A, Singh A, Anis A . Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis. Arthritis Res Ther. 2010; 12(5):R177. PMC: 2991008. DOI: 10.1186/ar3141. View

Berking M, Wupperman P, Reichardt A, Pejic T, Dippel A, Znoj H . Emotion-regulation skills as a treatment target in psychotherapy. Behav Res Ther. 2008; 46(11):1230-7. DOI: 10.1016/j.brat.2008.08.005. View

Jansson-Frojmark M, Norell-Clarke A, Linton S . The role of emotion dysregulation in insomnia: Longitudinal findings from a large community sample. Br J Health Psychol. 2015; 21(1):93-113. DOI: 10.1111/bjhp.12147. View

de Man-van Ginkel J, Gooskens F, Schepers V, Schuurmans M, Lindeman E, Hafsteinsdottir T . Screening for poststroke depression using the patient health questionnaire. Nurs Res. 2012; 61(5):333-41. DOI: 10.1097/NNR.0b013e31825d9e9e. View

Ruiz M, Zamorano E, Garcia-Campayo J, Pardo A, Freire O, Rejas J . Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affect Disord. 2010; 128(3):277-86. DOI: 10.1016/j.jad.2010.07.010. View

Wu J, Appleman E, Salazar R, Ong J . Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis. JAMA Intern Med. 2015; 175(9):1461-72. DOI: 10.1001/jamainternmed.2015.3006. View

Morin C, Benca R . Chronic insomnia. Lancet. 2012; 379(9821):1129-41. DOI: 10.1016/S0140-6736(11)60750-2. View

10.

Vega-Escano J, Porcel-Galvez A, de Diego-Cordero R, Romero-Sanchez J, Romero-Saldana M, Barrientos-Trigo S . Insomnia Interventions in the Workplace: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2020; 17(17). PMC: 7504457. DOI: 10.3390/ijerph17176401. View

11.

Kyle S, Miller C, Rogers Z, Siriwardena A, Macmahon K, Espie C . Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep. 2014; 37(2):229-37. PMC: 3900612. DOI: 10.5665/sleep.3386. View

12.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

13.

Espie C, Kyle S, Hames P, Cyhlarova E, Benzeval M . The daytime impact of DSM-5 insomnia disorder: comparative analysis of insomnia subtypes from the Great British Sleep Survey. J Clin Psychiatry. 2013; 73(12):e1478-84. DOI: 10.4088/JCP.12m07954. View

14.

Zachariae R, Lyby M, Ritterband L, OToole M . Efficacy of internet-delivered cognitive-behavioral therapy for insomnia - A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2015; 30:1-10. DOI: 10.1016/j.smrv.2015.10.004. View

15.

Ohayon M . Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2003; 6(2):97-111. DOI: 10.1053/smrv.2002.0186. View

16.

Vgontzas A, Liao D, Bixler E, Chrousos G, Vela-Bueno A . Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009; 32(4):491-7. PMC: 2663863. DOI: 10.1093/sleep/32.4.491. View

17.

Hafner M, Stepanek M, Taylor J, Troxel W, Van Stolk C . Why Sleep Matters-The Economic Costs of Insufficient Sleep: A Cross-Country Comparative Analysis. Rand Health Q. 2017; 6(4):11. PMC: 5627640. View

18.

Hasan F, Tu Y, Yang C, Gordon C, Wu D, Lee H . Comparative efficacy of digital cognitive behavioral therapy for insomnia: A systematic review and network meta-analysis. Sleep Med Rev. 2021; 61:101567. DOI: 10.1016/j.smrv.2021.101567. View

19.

Spitzer R, Kroenke K, Williams J . Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999; 282(18):1737-44. DOI: 10.1001/jama.282.18.1737. View

20.

Stewart R, Besset A, Bebbington P, Brugha T, Lindesay J, Jenkins R . Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep. 2006; 29(11):1391-7. DOI: 10.1093/sleep/29.11.1391. View